Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

VH Bio (Oligo Business)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of oligonucleotide synthesis services. The company operates a oligonucleotide synthesis firm offering diagnostics, nucleic, purification, micro PCR and monoclonal antibodies for immunologists and molecular biologists.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • Gateshead
  • England

VH Bio (Oligo Business) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore VH Bio (Oligo Business)‘s full profile, request access.

Request full access to PitchBook

VH Bio (Oligo Business) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore VH Bio (Oligo Business)‘s full profile, request access.

Request full access to PitchBook